This small single-center case-control study (50 MSAF vs 50 clear amniotic fluid, Koshi Zonal Hospital, Nepal, MarchβJuly 2006) reported markedly worse outcomes with meconium-stained amniotic fluid: cesarean delivery 66% vs 38% (p=0.005), low 1-minute Apgar (<5) 48% vs 6%, persistent low 5-minute Apgar (<7) 48% vs 12% (p<0.000), SCBU referral 34% vs 6% (p=0.000), and neonatal deaths 4 known (up to 9 counting 5 moribund discharges as deaths) vs 1 in controls (p=0.005)
Thickness mattered most: FHR abnormality occurred in 15/28 (53.6%) thick vs 2/22 (9.1%) thin MSAF (p=0.000), and mortality clustered in the thick group (4 of 4 known MSAF deaths)
Context and consistency: The direction of these findings agrees with a 2024 Indian observational study (thick MSAF: MAS 20% vs 3% thin; NICU 25% vs 5%) and a prospective Vellore cohort linking MSAF to chorioamnionitis (OR 4.2) and MAS . The reported MSAF incidence (27%) exceeds the 10β22% range the authors themselves cite, suggesting referral/selection bias in this tertiary zonal hospital.
Critical weaknesses: (1) No matching or confounder adjustment (parity, gestational age beyond "term", labor duration, comorbidities); (2) internal inconsistencies β the text reports p=0.005 for a 48% vs 6% Apgar difference that would be far more significant, and calls cesarean "38%" in controls while separately reporting instrumental delivery making operative delivery 42%; the claim that cesarean was higher in thin (72%) than thick (21%) meconium contradicts the paper's own conclusion that thick meconium worsens outcomes; (3) the mortality analysis counts 5 "assumed" deaths of moribund discharged infants β a post-hoc, unverifiable endpoint; (4) the p<0.2 for a 48% vs 6% Apgar difference is implausible; (5) no confidence intervals, no odds ratios, small n. A later rural NICU study shows similar inconsistency patterns in this literature, so results should be treated as hypothesis-generating .
What would change the conclusion: a larger controlled or randomized study showing no thick-vs-thin differential after adjusting for gestational age and labor duration; the intervention implication (CTG monitoring) also remains untested here β the meta-analysis evidence supports amnioinfusion rather than simply earlier cesarean . Notably, a retrospective thick-MSAF study found no outcome difference by delivery mode, cautioning against equating meconium presence with a need for cesarean .
Author reviews:
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.